These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 15536604)
1. Effect of pioglitazone on the early stage of type 2 diabetic nephropathy in KK/Ta mice. Tanimoto M; Fan Q; Gohda T; Shike T; Makita Y; Tomino Y Metabolism; 2004 Nov; 53(11):1473-9. PubMed ID: 15536604 [TBL] [Abstract][Full Text] [Related]
2. Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy. Sugimoto H; Shikata K; Matsuda M; Kushiro M; Hayashi Y; Hiragushi K; Wada J; Makino H Diabetologia; 1998 Dec; 41(12):1426-34. PubMed ID: 9867209 [TBL] [Abstract][Full Text] [Related]
3. Glomerular changes in the KK-Ay/Ta mouse: a possible model for human type 2 diabetic nephropathy. Ito T; Tanimoto M; Yamada K; Kaneko S; Matsumoto M; Obayashi K; Hagiwara S; Murakoshi M; Aoki T; Wakabayashi M; Gohda T; Funabiki K; Maeda K; Horikoshi S; Tomino Y Nephrology (Carlton); 2006 Feb; 11(1):29-35. PubMed ID: 16509929 [TBL] [Abstract][Full Text] [Related]
4. Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice. Liao J; Kobayashi M; Kanamuru Y; Nakamura S; Makita Y; Funabiki K; Horikoshi S; Tomino Y J Nephrol; 2003; 16(6):841-9. PubMed ID: 14736011 [TBL] [Abstract][Full Text] [Related]
5. Beraprost sodium, prostacyclin analogue, attenuates glomerular hyperfiltration and glomerular macrophage infiltration by modulating ecNOS expression in diabetic rats. Yamashita T; Shikata K; Matsuda M; Okada S; Ogawa D; Sugimoto H; Wada J; Makino H Diabetes Res Clin Pract; 2002 Sep; 57(3):149-61. PubMed ID: 12126764 [TBL] [Abstract][Full Text] [Related]
6. Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice. Fan Q; Liao J; Kobayashi M; Yamashita M; Gu L; Gohda T; Suzuki Y; Wang LN; Horikoshi S; Tomino Y Nephrol Dial Transplant; 2004 Dec; 19(12):3012-20. PubMed ID: 15574998 [TBL] [Abstract][Full Text] [Related]
7. Nitric oxide system is involved in glomerular hyperfiltration in Japanese normo- and micro-albuminuric patients with type 2 diabetes. Hiragushi K; Sugimoto H; Shikata K; Yamashita T; Miyatake N; Shikata Y; Wada J; Kumagai I; Fukushima M; Makino H Diabetes Res Clin Pract; 2001 Sep; 53(3):149-59. PubMed ID: 11483230 [TBL] [Abstract][Full Text] [Related]
8. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy. Veelken R; Hilgers KF; Hartner A; Haas A; Böhmer KP; Sterzel RB J Am Soc Nephrol; 2000 Jan; 11(1):71-79. PubMed ID: 10616842 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes. Schrijvers BF; De Vriese AS; Tilton RG; Van de Voorde J; Denner L; Lameire NH; Flyvbjerg A Horm Metab Res; 2005 Jan; 37(1):21-5. PubMed ID: 15702434 [TBL] [Abstract][Full Text] [Related]
11. Relations between ACE gene and ecNOS gene polymorphisms and resistive index in type 2 diabetic patients with nephropathy. Taniwaki H; Ishimura E; Matsumoto N; Emoto M; Inaba M; Nishizawa Y Diabetes Care; 2001 Sep; 24(9):1653-60. PubMed ID: 11522715 [TBL] [Abstract][Full Text] [Related]
12. Tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, suppresses renal damage in KKAy/Ta mice, obese and type 2 diabetic animals. Ishibashi Y; Matsui T; Yamagishi SI Diab Vasc Dis Res; 2016 Nov; 13(6):438-441. PubMed ID: 27407083 [TBL] [Abstract][Full Text] [Related]
13. Effect of pitavastatin on type 2 diabetes mellitus nephropathy in KK-Ay/Ta mice. Matsumoto M; Tanimoto M; Gohda T; Aoki T; Murakoshi M; Yamada K; Yamazaki T; Kaneko S; Horikoshi S; Tomino Y Metabolism; 2008 May; 57(5):691-7. PubMed ID: 18442635 [TBL] [Abstract][Full Text] [Related]
14. Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice. Tanimoto M; Gohda T; Kaneko S; Hagiwara S; Murakoshi M; Aoki T; Yamada K; Ito T; Matsumoto M; Horikoshi S; Tomino Y Metabolism; 2007 Feb; 56(2):160-7. PubMed ID: 17224327 [TBL] [Abstract][Full Text] [Related]
15. Effects of vitamin D combined with pioglitazone hydrochloride on bone mineral density and bone metabolism in Type 2 diabetic nephropathy. Wang LX; Wang N; Xu QL; Yan W; Dong L; Li BL Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28153916 [TBL] [Abstract][Full Text] [Related]
16. Involvement of hyperglycemia in deposition of aggregated protein in glomeruli of diabetic mice. Hirasawa Y; Matsui Y; Ohtsu S; Yamane K; Toyoshi T; Kyuki K; Sakai T; Feng Y; Nagamatsu T Eur J Pharmacol; 2008 Dec; 601(1-3):129-35. PubMed ID: 18950619 [TBL] [Abstract][Full Text] [Related]
17. Dual therapy of vildagliptin and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats. Sharma AK; Kanawat DS; Mishra A; Dhakad PK; Sharma P; Srivastava V; Joshi S; Joshi M; Raikwar SK; Kurmi MK; Srinivasan BP J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):410-8. PubMed ID: 23396552 [TBL] [Abstract][Full Text] [Related]
18. Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy. Kobayashi S; Satoh M; Namikoshi T; Haruna Y; Fujimoto S; Arakawa S; Komai N; Tomita N; Sasaki T; Kashihara N Clin Exp Nephrol; 2008 Apr; 12(2):119-125. PubMed ID: 18175064 [TBL] [Abstract][Full Text] [Related]
19. Pioglitazone ameliorates glomerular NLRP3 inflammasome activation in apolipoprotein E knockout mice with diabetes mellitus. Wang Y; Yu B; Wang L; Yang M; Xia Z; Wei W; Zhang F; Yuan X PLoS One; 2017; 12(7):e0181248. PubMed ID: 28708885 [TBL] [Abstract][Full Text] [Related]
20. The role of adrenomedullin and receptors in glomerular hyperfiltration in streptozotocin-induced diabetic rats. Hiragushi K; Wada J; Eguchi J; Matsuoka T; Yasuhara A; Hashimoto I; Yamashita T; Hida K; Nakamura Y; Shikata K; Minamino N; Kangawa K; Makino H Kidney Int; 2004 Feb; 65(2):540-50. PubMed ID: 14717924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]